Canada: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Health Canada Issues Revised Biosimilar Guidance Reducing Clinical Evidence Requirements For Biosimilar Approval

Health Canada has issued a new Guidance Document pertaining to biosimilar drug submissions. The new Guidance significantly reduces the supporting clinical safety...

Canada Healthcare

GW

Gowling WLG

PMPRB Releases May NEWSLetter And Meds Pipeline Monitor

On May 12, 2026, the Patented Medicine Prices Review Board (PMPRB) released its May NEWSLetter. The NEWSletter provides updates on the implementation of the new Guidelines for PMPRB Staff, the consultation of the proposed Hearing Practice Directions, events in which the PMPRB participated, and new and upcoming NPDUIS research publications.

Canada Healthcare

SB

Smart & Biggar

Canada’s Drug Agency Releases Updated Procedures For Reimbursement Reviews & New Data On Health Technology Assessment Timelines

On April 30, 2026, Canada’s Drug Agency (CDA) published updated Procedures for Reimbursement Reviews, following completion of a public consultation earlier this year. The updated procedures will be effective for August 2026 submissions and expert committee meetings in January 2027.

Canada Healthcare

SB

Smart & Biggar

Health Canada Seeks Feedback On Phased Implementation Of The Incorporated By Reference List For Ministerial Reliance Order

As previously reported, Health Canada has proposed a Ministerial Reliance Order that would allow Health Canada to rely on decisions of foreign regulatory authorities (FRAs). Health Canada has proposed that the Reliance Order will come into force in summer 2026, at which point Health Canada will consult on an applicable guidance document.

Canada Healthcare

SB

Smart & Biggar

Dormant DINs Revisited: MFN Pricing And The Evolving Impacts On Canada’s Patent Linkage Regime

F

Fasken

Health Canada Removes Phase III Trials For Biosimilars: What It Means For Patent Enforcement

Canada Healthcare

MT

McCarthy Tétrault LLP

Health Canada Proposes To Exempt Certain Low-risk Non-prescription Drugs From “New Drug” Requirements

Canada Healthcare

GW

Gowling WLG

Le CEPMB publie son édition de mai de la Nouvelle et L’Observateur des médicaments émergents

Canada Healthcare

SB

Smart & Biggar

Les aspects réglementaires et liés à la propriété intellectuelle encadrant les médicaments vétérinaires au Canada

Canada Healthcare

SB

Smart & Biggar

Crime Does Not Pay, Even Without A Conviction: New Legal Test For Criminal Forfeiture Under Section 490(9) Of The Criminal Code Set Out In R V. Nguyen, 2026 SCC 10

Canada Criminal

AH

Alexander Holburn Beaudin + Lang LLP

Le problème des DIN dormants au Canada : comment le statut de commercialisation sape les protections de la PI pharmaceutique prévues à l’ACEUM

Canada Healthcare

MT

McCarthy Tétrault LLP

Regulatory And IP Considerations For Veterinary Drugs In Canada

SB

Smart & Biggar

L’Agence des médicaments du Canada publie une mise à jour des procédures relatives aux examens en vue du remboursement et de nouvelles données sur les délais d’évaluation des technologies de la santé

Canada Healthcare

SB

Smart & Biggar

Canada Strong For All: Highlights From The 2026 Spring Economic Update

Canada Strategy

GW

Gowling WLG

Cyber Criminals Love Your Deals: How Hidden Cyber Risk Can Blow Up Your M&A (And What To Do About It)

MT

Miller Thomson LLP

A Guide To Canadian Corporate Dividend Tax Strategy

RS

Rotfleisch & Samulovitch P.C.

New Principles For AI Use In Ontario

Canada Technology

MT

Miller Thomson LLP

CRA vs. IRS Audits: What Every Canadian Tax Lawyer Wants You To Know

RS

Rotfleisch & Samulovitch P.C.

Walking The Journey With Founders: Joe Gill’s Approach To Supporting Saskatchewan Startups (Video)

Canada Commercial

ML

McKercher LLP

Canada Strong For All: Highlights From The 2026 Spring Economic Update

The Spring Economic Update (“Update”) was tabled in the House of Commons against a backdrop of heightened global instability, particularly oil price market volatility caused by the conflict in the Middle East...

Canada Strategy

GW

Gowling WLG

Guerres De Frites : La CAF Confirme Une Interprétation Fondée Sur La Déférence Des Revendications De Brevets Dans McCain v. Simplot

Dans McCain Foods Limited v. J.R. Simplot Company, 2026 FCA 71 (« McCain Foods »), la Cour d’appel fédérale (« CAF »)...

MT

McCarthy Tétrault LLP

Northern Advantage: Canada's Federal Court As A Venue For Pharmaceutical Patent Litigation

In the complex and high-stakes world of pharmaceutical patent litigation, selecting the right venue can significantly influence the outcome of a case. For companies marketing or seeking to market pharmaceuticals in Canada...

BJ

Bennett Jones LLP

Work Permits And Immigration Strategies For Canada’s Food Processing Employers

Green and Spiegel LLP is a leading immigration law firm serving clients across Canada and the United States, offering comprehensive corporate and individual immigration services.

Canada Immigration

Gs

Green and Spiegel

Health Canada Reclassifies Sports Electrolyte Products As Foods

Canada Healthcare

GW

Gowling WLG

Mise à jour sur les instruments médicaux : utilisation obligatoire du processus d’inscription réglementaire pour les instruments médicaux et mise à jour des lignes directrices relatives à ce processus

Canada Healthcare

SB

Smart & Biggar

Un Nouveau Marché : Les Prêts-à-boire À Base De Spiritueux Arrivent Dans Les Épiceries Du Québec

Canada Healthcare

FF

Fasken (French)

A New Channel: Spirit-Based Ready-To-Drink Beverages In Quebec Grocery Stores

Canada Healthcare

F

Fasken

What Producers Need To Know About Health Canada’s Latest Food Additive, Enzyme And Supplement Updates

Canada Healthcare

MA

MLT Aikins LLP

NEW: Ad Standards’ Updated Code For Food & Beverage Advertising To Children

Canada Healthcare

F

Fasken

NEW: Ad Standards’ Updated Code For Food & Beverage Advertising To Children

Canada Healthcare

F

Fasken

CFIA Addresses Stakeholders’ "Eggspectations” Regarding Proposed Guidance On Plant‑Based Egg Alternatives

Canada Healthcare

F

Fasken

Canada's Dormant DIN Problem: How Marketing Status Is Undermining Pharmaceutical IP Protections Under CUSMA

MT

McCarthy Tétrault LLP

Federal Court Dismisses C$5 Billion Generic Drug Price-Fixing Class Action

Canada Healthcare

BJ

Bennett Jones LLP

NEW: Ad Standards’ Updated Code For Food & Beverage Advertising To Children

Recently, Ad Standards Canada published the updated Code for the Restriction of Food and Beverage Product Advertising to Children (the “Updated Code”), replacing the earlier Code for the Responsible Advertising of Food and Beverage Products to Children.

Canada Healthcare

F

Fasken

CFIA Addresses Stakeholders’ "Eggspectations” Regarding Proposed Guidance On Plant‑Based Egg Alternatives

In January 2026, the Canadian Food Inspection Agency (“CFIA”) released the What we heard report: Consultation on proposed guidance on how to label and represent plant-based alternatives to egg products (the “Report”)...

Canada Healthcare

F

Fasken

Canada's Dormant DIN Problem: How Marketing Status Is Undermining Pharmaceutical IP Protections Under CUSMA

When Canada ratified the Canada–United States–Mexico Agreement (CUSMA), it signalled a policy commitment to a stable and predictable intellectual property (IP) framework that supports pharmaceutical innovation...

MT

McCarthy Tétrault LLP

Federal Court Dismisses C$5 Billion Generic Drug Price-Fixing Class Action

The Federal Court of Canada has found that a C$5 billion class action alleging an industry-wide conspiracy to fix generic drug prices in Canada has no basis in fact.

Canada Healthcare

BJ

Bennett Jones LLP

Canada's Agri-food Equity Gap: Why Growth Capital Is The Sector's Missing Ingredient

Canada Healthcare

MA

MLT Aikins LLP

Packaging Regulation Accelerates: What Businesses In The Food, Beverage And Agribusiness Sector Need To Know

The regulation of plastics and packaging in Canada is evolving rapidly at both the federal and provincial levels. Recent developments — including expanded extended producer responsibility (EPR)...

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

Canada Launches Safeguard Inquiry Into Frozen And Canned Vegetable Imports

The Canadian International Trade Tribunal (CITT) has initiated a safeguard inquiry that may have significant implications for businesses involved in the production...

Canada International

C

Cassels

Could Artificial Intelligence Soon Prescribe Drugs In Canada? Lessons From Utah's Landmark Program

Canadian regulators may soon face new questions about the role of autonomous artificial intelligence ("AI") in healthcare delivery, as the state of Utah has launched a pilot program...

Canada Healthcare

F

Fasken

Torys On Defence: The Role Of Life Sciences In Canada's Defence Capabilities

Last month, Canada released its first Defence Industrial Strategy (the Strategy), which outlines Canada's commitment to develop a strong defence industrial base and boost economic growth.

Canada Healthcare

TL

Torys LLP

New Controlled Substances Regulations To Consolidate Existing Regulatory Scheme

Canada Healthcare

TL

Torys LLP

Aller de l'avant: Points clés du 16e Sommet du commerce de détail et des biens de consommation

Canada Consumer

MT

McCarthy Tétrault LLP

U.S.–Canada Tariffs: Timeline Of Key Dates And Documents

Canada International

BC

Blake, Cassels & Graydon LLP

Health Canada Eliminates The Foreign Site Reference Number (FSRN) Process: Immediate Impact On Importers And Foreign Sites

Canada Healthcare

GW

Gowling WLG

Driving Forward: Key Takeaways From The 16th Anniversary Edition Of McCarthy Tétrault's Annual Retail And Consumer Markets Summit

Worldwide Consumer

MT

McCarthy Tétrault LLP

Federal Court Denies Class Action Certification In Generic Drug Price Fixing Case

Canada Healthcare

SB

Smart & Biggar

La Cour fédérale rejette une requête en autorisation de recours collectif relative à la fixation des prix de médicaments génériques

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada annonce une consultation sur le processus d'examen simplifié et de nouvelles procédures en ce qui concerne les reconsidérations et les nouvelles demandes d'examen

Canada Healthcare

SB

Smart & Biggar

Proposed Regulatory Framework Aims To Better Support Innovative Clinical Trials In Canada

Canada Healthcare

TL

Torys LLP

Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

Canada Healthcare

SB

Smart & Biggar

Canadian Product Stewardship And EPR: A Review Of 2025 And Beyond

Canada Environment

GW

Gowling WLG

New PMPRB Chairperson And PMPRB Releases January 2026 NEWSletter

Canada Healthcare

SB

Smart & Biggar

Nouvelle présidente au CEPMB et publication de l'édition de janvier 2026 de la Nouvelle du CEPMB

SB

Smart & Biggar

Legislative Update Report No. 2026-04 Le Bulletin D'actualités Législatives

Canada Government

OH

Osler, Hoskin & Harcourt LLP

Ce Que Les Organismes De Santé Doivent Savoir Sur Les Nouvelles Directives Entourant La Transcription Par IA En Ontario, En Colombie-Britannique Et En Alberta

Canada Technology

BL

Borden Ladner Gervais LLP

See more

Latest Videos

See more

From Discovery To Market: The Role Of IP Strategy In Drug Development (Video)

GW

Gowling WLG

Drug Pricing And Reimbursement: The Role Of Provinces And Hospitals In Pharmaceutical Pricing (Video)

TL

Torys LLP

What Are The Challenges And Opportunities In Ontario's Budding Cannabis Retail Market? (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Seven: Tracking Ailments (Video)

D

Dentons Canada LLP

2018 Legal Year In Review (Video)

OH

Osler, Hoskin & Harcourt LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More